10 20 30 40 50 60 70 80 2HY2 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER 04-AUG-06 2HY2
TITLE THEORETICAL MODEL OF RET PROTEIN KINASE COMPLEXED WITH ATP TITLE 2 BASED ON THE INSULIN RECEPTOR TYROSINE PROTEIN KINASE X- TITLE 3 RAY STRUCTURE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: RET RECEPTOR TYROSINE PROTEIN KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN OF RET (REARRANGED DURING COMPND 5 TRANSFECTION); COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THEORETICAL MODEL
KEYWDS PROTEIN KINASE
EXPDTA THEORETICAL MODEL
AUTHOR SUSAN S.TAYLOR,ELZBIETA S.RADZIO-ANDZELM
REVDAT 1 10-OCT-06 2HY2 0
JRNL AUTH A.N.CRANSTON,C.CARNITI,K.OAKHILL,E.RADZIO-ANDZELM, JRNL AUTH 2 E.A.STONE,A.S.MCCALLION,S.HODGSON,S.CLARKE, JRNL AUTH 3 P.MONDELLINI,B.A.J.LEYLAND,J.,PIEROTTI,M.A., JRNL AUTH 4 WHITTAKER,J.,TAYLOR,S.S.,BONGARZONE,I.,PONDER JRNL TITL RET IS CONSTITUTIVELY ACTIVATED BY NOVEL TANDEM JRNL TITL 2 MUTATIONS THAT ALTER THE ACTIVE SITE RESULTING IN JRNL TITL 3 MEN 2B JRNL REF CANCER RESEARCH V.ACCE 2006
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2HY2 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 04-AUG-2006. REMARK 100 THE RCSB ID CODE IS RCSB038896.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS MODEL WAS PRODUCED BY HOMOLOGY STARTING FROM REMARK 220 INSULIN RECEPTOR TYROSINE KINASE STRUCTURE PDB ID 1IR3. REMARK 220 THIS THEORETICAL MODEL ENTRY WAS NOT ANNOTATED AND NOT REMARK 220 VALIDATED BY THE WWPDB STAFF AND THEREFORE MAY NOT REMARK 220 CONFORM TO THE PDB FORMAT.
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 822 REMARK 465 GLY A 823 REMARK 465 PRO A 824 REMARK 465 GLY A 825 REMARK 465 TYR A 826 REMARK 465 LEU A 827 REMARK 465 GLY A 828 REMARK 465 SER A 829 REMARK 465 GLY A 830 REMARK 465 GLY A 831 REMARK 465 SER A 832 REMARK 465 ARG A 833 REMARK 465 ASN A 834 REMARK 465 SER A 835 REMARK 465 SER A 836 REMARK 465 SER A 837 REMARK 465 LEU A 838 REMARK 465 ASP A 839 REMARK 465 HIS A 840 REMARK 465 PRO A 841 REMARK 465 ASP A 842 REMARK 465 GLU A 843 REMARK 465 ARG A 844 REMARK 465 ALA A 845 REMARK 465 ALA A 1019 REMARK 465 ALA A 1020 REMARK 465 SER A 1021 REMARK 465 THR A 1022 REMARK 465 PRO A 1023 REMARK 465 SER A 1024 REMARK 465 ASP A 1025 REMARK 465 SER A 1026 REMARK 465 LEU A 1027 REMARK 465 ILE A 1028 REMARK 465 TYR A 1029 REMARK 465 ASP A 1030 REMARK 465 ASP A 1031 REMARK 465 GLY A 1032 REMARK 465 LEU A 1033 REMARK 465 SER A 1034 REMARK 465 GLU A 1035 REMARK 465 GLU A 1036 REMARK 465 GLU A 1037 REMARK 465 THR A 1038 REMARK 465 PRO A 1039 REMARK 465 LEU A 1040 REMARK 465 VAL A 1041 REMARK 465 ASP A 1042 REMARK 465 CYS A 1043 REMARK 465 ASN A 1044 REMARK 465 ASN A 1045 REMARK 465 ALA A 1046 REMARK 465 PRO A 1047 REMARK 465 LEU A 1048 REMARK 465 PRO A 1049 REMARK 465 ARG A 1050 REMARK 465 ALA A 1051 REMARK 465 LEU A 1052 REMARK 465 PRO A 1053 REMARK 465 SER A 1054 REMARK 465 THR A 1055 REMARK 465 TRP A 1056 REMARK 465 ILE A 1057 REMARK 465 GLU A 1058 REMARK 465 ASN A 1059 REMARK 465 LYS A 1060 REMARK 465 LEU A 1061 REMARK 465 TYR A 1062 REMARK 465 GLY A 1063 REMARK 465 ARG A 1064 REMARK 465 ILE A 1065 REMARK 465 SER A 1066 REMARK 465 HIS A 1067 REMARK 465 ALA A 1068 REMARK 465 PHE A 1069 REMARK 465 THR A 1070 REMARK 465 ARG A 1071 REMARK 465 PHE A 1072
DBREF 2HY2 A 713 1072 UNP Q15850 Q15850_HUMAN 76 435
SEQRES 1 A 360 GLU ASP PRO LYS TRP GLU PHE PRO ARG LYS ASN LEU VAL SEQRES 2 A 360 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY LYS VAL SEQRES 3 A 360 VAL LYS ALA THR ALA PHE HIS LEU LYS GLY ARG ALA GLY SEQRES 4 A 360 TYR THR THR VAL ALA VAL LYS MET LEU LYS GLU ASN ALA SEQRES 5 A 360 SER PRO SER GLU LEU ARG ASP LEU LEU SER GLU PHE ASN SEQRES 6 A 360 VAL LEU LYS GLN VAL ASN HIS PRO HIS VAL ILE LYS LEU SEQRES 7 A 360 TYR GLY ALA CYS SER GLN ASP GLY PRO LEU LEU LEU ILE SEQRES 8 A 360 VAL GLU TYR ALA LYS TYR GLY SER LEU ARG GLY PHE LEU SEQRES 9 A 360 ARG GLU SER ARG LYS VAL GLY PRO GLY TYR LEU GLY SER SEQRES 10 A 360 GLY GLY SER ARG ASN SER SER SER LEU ASP HIS PRO ASP SEQRES 11 A 360 GLU ARG ALA LEU THR MET GLY ASP LEU ILE SER PHE ALA SEQRES 12 A 360 TRP GLN ILE SER GLN GLY MET GLN TYR LEU ALA GLU MET SEQRES 13 A 360 LYS LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU SEQRES 14 A 360 VAL ALA GLU GLY ARG LYS MET LYS ILE SER ASP PHE GLY SEQRES 15 A 360 LEU SER ARG ASP VAL TYR GLU GLU ASP SER TYR VAL LYS SEQRES 16 A 360 ARG SER GLN GLY ARG ILE PRO VAL LYS TRP MET ALA ILE SEQRES 17 A 360 GLU SER LEU PHE ASP HIS ILE TYR THR THR GLN SER ASP SEQRES 18 A 360 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE VAL THR SEQRES 19 A 360 LEU GLY GLY ASN PRO TYR PRO GLY ILE PRO PRO GLU ARG SEQRES 20 A 360 LEU PHE ASN LEU LEU LYS THR GLY HIS ARG MET GLU ARG SEQRES 21 A 360 PRO ASP ASN CYS SER GLU GLU MET TYR ARG LEU MET LEU SEQRES 22 A 360 GLN CYS TRP LYS GLN GLU PRO ASP LYS ARG PRO VAL PHE SEQRES 23 A 360 ALA ASP ILE SER LYS ASP LEU GLU LYS MET MET VAL LYS SEQRES 24 A 360 ARG ARG ASP TYR LEU ASP LEU ALA ALA SER THR PRO SER SEQRES 25 A 360 ASP SER LEU ILE TYR ASP ASP GLY LEU SER GLU GLU GLU SEQRES 26 A 360 THR PRO LEU VAL ASP CYS ASN ASN ALA PRO LEU PRO ARG SEQRES 27 A 360 ALA LEU PRO SER THR TRP ILE GLU ASN LYS LEU TYR GLY SEQRES 28 A 360 ARG ILE SER HIS ALA PHE THR ARG PHE
HET ATP 542 31
HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE
FORMUL 2 ATP C10 H16 N5 O13 P3
HELIX 1 1 PRO A 720 LYS A 722 5 3 HELIX 2 2 SER A 765 VAL A 782 1 18 HELIX 3 3 LEU A 812 SER A 819 1 8 HELIX 4 4 THR A 847 MET A 868 1 22 HELIX 5 5 ALA A 919 PHE A 924 1 6 HELIX 6 6 GLN A 931 THR A 946 1 16 HELIX 7 7 PRO A 956 GLY A 967 1 12 HELIX 8 8 SER A 977 TRP A 988 1 12 HELIX 9 9 VAL A 997 SER A 1002 1 6
SHEET 1 A 5 LEU A 724 GLU A 732 0 SHEET 2 A 5 GLY A 736 ALA A 743 -1 O VAL A 738 N LEU A 730 SHEET 3 A 5 THR A 753 LEU A 760 -1 O VAL A 755 N ALA A 741 SHEET 4 A 5 LEU A 801 GLU A 805 -1 O LEU A 802 N LYS A 758 SHEET 5 A 5 LEU A 790 CYS A 794 -1 N TYR A 791 O ILE A 803 SHEET 1 B 3 GLY A 810 SER A 811 0 SHEET 2 B 3 LEU A 881 VAL A 882 -1 O VAL A 882 N GLY A 810 SHEET 3 B 3 MET A 888 LYS A 889 -1 O LYS A 889 N LEU A 881 SHEET 1 C 2 LEU A 870 VAL A 871 0 SHEET 2 C 2 ARG A 897 ASP A 898 -1 O ARG A 897 N VAL A 871 SHEET 1 D 2 SER A 904 VAL A 906 0 SHEET 2 D 2 ILE A 927 THR A 929 -1 O TYR A 928 N TYR A 905
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000